Q2 2025 · 13F-HR
HHLR ADVISORS, LTD.holdings as filed
Filed 2025-08-14 · accession 0000902664-25-003621
$3.10B
Reported value
36
Positions
2025-06-30
Period end
The Brief · HHLR ADVISORS, LTD. · Q2 2025
AI · grounded in 13F
HHLR ADVISORS, LTD. established a new position in PDD valued at $730.2M. The fund also initiated new stakes in FUTU for $532.9M and BULL for $395.6M. Other new additions include ONC at $250.4M and NTES at $223.9M. Total assets under management stand at $3.1B across 36 positions.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 722304102 | PDD | PDD HOLDINGS INC | $730.2M | 23.5% | 6,976,804 | Common | SHARED |
| 36118L106 | FUTU | FUTU HLDGS LTD | $532.9M | 17.2% | 4,312,237 | Common | SHARED |
| G9572D103 | BULL | WEBULL CORP | $395.6M | 12.7% | 33,080,846 | Common | SHARED |
| 07725L102 | ONC | BEONE MEDICINES LTD | $250.4M | 8.06% | 1,034,306 | Common | SHARED |
| 64110W102 | NTES | NETEASE INC | $223.9M | 7.21% | 1,663,668 | Common | SHARED |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $212.4M | 6.84% | 5,984,550 | Common | SHARED |
| 482497104 | BEKE | KE HLDGS INC | $132.4M | 4.27% | 7,465,465 | Common | SHARED |
| 01609W102 | BABA | ALIBABA GROUP HLDG LTD | $130.4M | 4.20% | 1,149,700 | Common | SHARED |
| 04272N102 | AVBP | ARRIVENT BIOPHARMA INC | $97.6M | 3.14% | 4,484,672 | Common | SHARED |
| G98196101 | W9N0 | WNS HLDGS LTD | $96.8M | 3.12% | 1,531,466 | Common | SHARED |
| 47215P106 | JD | JD.COM INC | $74.3M | 2.39% | 2,275,500 | Common | SHARED |
| 985194208 | YSG | YATSEN HLDG LTD | $58.9M | 1.90% | 6,111,933 | Common | SHARED |
| 185123106 | CWAN | CLEARWATER ANALYTICS HLDGS I | $30.0M | 0.96% | 1,365,971 | Common | SHARED |
| 23285D109 | CTKB | CYTEK BIOSCIENCES INC | $22.6M | 0.73% | 6,657,030 | Common | SHARED |
| 92763W103 | VIPS | VIPSHOP HLDGS LTD | $17.0M | 0.55% | 1,131,788 | Common | SHARED |
| 50202M102 | LI | LI AUTO INC | $16.8M | 0.54% | 620,000 | Common | SHARED |
| 44975P103 | NBP | I MAB | $14.5M | 0.47% | 5,980,568 | Common | SHARED |
| 98980A105 | ZTO | ZTO EXPRESS CAYMAN INC | $11.9M | 0.38% | 671,387 | Common | SHARED |
| 48553T106 | BZ | KANZHUN LIMITED | $10.3M | 0.33% | 576,339 | Common | SHARED |
| 00851L103 | API | AGORA INC | $8.0M | 0.26% | 2,098,553 | Common | SHARED |
| 38341P102 | GOSS | GOSSAMER BIO INC | $6.1M | 0.20% | 4,974,041 | Common | SHARED |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $5.6M | 0.18% | 457,535 | Common | SHARED |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $5.5M | 0.18% | 724,800 | Common | SHARED |
| 83193E102 | EM | SMART SH GLOBAL LTD | $4.5M | 0.15% | 3,949,700 | Common | SHARED |
| 90114C107 | TUYA | TUYA INC | $3.6M | 0.12% | 1,564,400 | Common | SHARED |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $2.7M | 0.09% | 669,337 | Common | SHARED |
| 608012308 | MOGU | MOGU INC | $1.8M | 0.06% | 847,510 | Common | SHARED |
| 109199208 | BEDU | BRIGHT SCHOLAR ED HLDGS LTD | $1.7M | 0.06% | 988,143 | Common | SHARED |
| 369604301 | GE | GE AEROSPACE | $1.6M | 0.05% | 6,305 | Common | SHARED |
| 615369105 | MCO | MOODYS CORP | $1.2M | 0.04% | 2,476 | Common | SHARED |
| 55354G100 | MSCI | MSCI INC | $1.2M | 0.04% | 2,008 | Common | SHARED |
| 69404D108 | PACB | PACIFIC BIOSCIENCES CALIF IN | $1.1M | 0.04% | 918,892 | Common | SHARED |
| 01626L204 | ALGS | ALIGOS THERAPEUTICS INC | $549,741 | 0.02% | 76,247 | Common | SHARED |
| G9845F208 | LSBCF | LAKESHORE BIOPHARMA CO LTD | $76,683 | 0.00% | 75,179 | Common | SHARED |
| 91818X306 | UXIN | UXIN LTD | $70,494 | 0.00% | 19,156 | Common | SHARED |
| G2124G120 | RDGT | RIDGETECH INC | $22,184 | 0.00% | 20,167 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.